0001104659-20-139119.txt : 20201223
0001104659-20-139119.hdr.sgml : 20201223
20201223161930
ACCESSION NUMBER: 0001104659-20-139119
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201221
FILED AS OF DATE: 20201223
DATE AS OF CHANGE: 20201223
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Cheng Andrew
CENTRAL INDEX KEY: 0001778307
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38944
FILM NUMBER: 201412498
MAIL ADDRESS:
STREET 1: 170 HARBOR WAY, 3RD FLOOR
STREET 2: C/O AKERO THERAPEUTICS, INC.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Akero Therapeutics, Inc.
CENTRAL INDEX KEY: 0001744659
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 601 GATEWAY BOULEVARD, SUITE 350
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-487-6488
MAIL ADDRESS:
STREET 1: 601 GATEWAY BOULEVARD, SUITE 350
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
tm2039296d1_4.xml
OWNERSHIP DOCUMENT
X0306
4
2020-12-21
0
0001744659
Akero Therapeutics, Inc.
AKRO
0001778307
Cheng Andrew
C/O AKERO THERAPEUTICS, INC.
601 GATEWAY BOULEVARD, SUITE 350
SOUTH SAN FRANCISCO
CA
94080
1
1
0
0
President & CEO
Common Stock
2020-12-11
5
G
0
E
50
0
D
327509
D
Common Stock
2020-12-15
5
G
0
E
2500
0
D
325009
D
Common Stock
2020-12-21
4
M
0
10500
0.62
A
335509
D
Employee Stock Option (Right to Buy)
0.62
2020-12-21
4
M
0
10500
0
D
2028-09-07
Common Stock
10500
286192
D
The shares reported in this transaction represent a bona fide gift.
The shares reported in this transaction represent a bona fide charitable gift to a donor advised fund. The Reporting Person does not have any pecuniary interest in the fund's assets.
25% of this option vested and became exercisable on September 1, 2019, with the remainder vesting in 36 equal monthly installments thereafter.
/s/ Jonathan Young, Attorney-in-Fact
2020-12-23